Cargando…

Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation

Selective blockers of the Kv1.5 channel have been developed for the treatment of atrial fibrillation (AF), but little is known how these atrial-selective drugs affect human action potentials (APs). Therefore we have investigated the Kv1.5 blocker MK-0448 (N-{6-[(1S)-1-(4-fluorophenyl)-2,2-di(pyridin...

Descripción completa

Detalles Bibliográficos
Autores principales: Loose, Simone, Mueller, Judith, Wettwer, Erich, Knaut, Michael, Ford, John, Milnes, James, Ravens, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940943/
https://www.ncbi.nlm.nih.gov/pubmed/24624083
http://dx.doi.org/10.3389/fphar.2014.00026
_version_ 1782305840921837568
author Loose, Simone
Mueller, Judith
Wettwer, Erich
Knaut, Michael
Ford, John
Milnes, James
Ravens, Ursula
author_facet Loose, Simone
Mueller, Judith
Wettwer, Erich
Knaut, Michael
Ford, John
Milnes, James
Ravens, Ursula
author_sort Loose, Simone
collection PubMed
description Selective blockers of the Kv1.5 channel have been developed for the treatment of atrial fibrillation (AF), but little is known how these atrial-selective drugs affect human action potentials (APs). Therefore we have investigated the Kv1.5 blocker MK-0448 (N-{6-[(1S)-1-(4-fluorophenyl)-2,2-di(pyridin-3-yl)ethyl]pyridin-2-yl}methanesulfon- amide) in right atrial trabeculae from patients in sinus rhythm (SR), permanent AF (>6 months), and intermittent AF. MK-0448 blocked Kv1.5 current in an expression system and concentration-dependently elevated the plateau phase of atrial APs. In SR preparations stimulated at 1 Hz, MK-0448 (3 μM) shortened action potential duration at 90% of repolarization (APD(90)) and effective refractory period (ERP), but in permanent AF preparations, MK-0448 prolonged APD(90) and ERP. The effects of MK-0448 in intermittent AF resembled those in SR preparations. Block of I(Ks) is probably more prominent in AF because of reduced repolarization reserve due to AF-induced remodeling.
format Online
Article
Text
id pubmed-3940943
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-39409432014-03-12 Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation Loose, Simone Mueller, Judith Wettwer, Erich Knaut, Michael Ford, John Milnes, James Ravens, Ursula Front Pharmacol Pharmacology Selective blockers of the Kv1.5 channel have been developed for the treatment of atrial fibrillation (AF), but little is known how these atrial-selective drugs affect human action potentials (APs). Therefore we have investigated the Kv1.5 blocker MK-0448 (N-{6-[(1S)-1-(4-fluorophenyl)-2,2-di(pyridin-3-yl)ethyl]pyridin-2-yl}methanesulfon- amide) in right atrial trabeculae from patients in sinus rhythm (SR), permanent AF (>6 months), and intermittent AF. MK-0448 blocked Kv1.5 current in an expression system and concentration-dependently elevated the plateau phase of atrial APs. In SR preparations stimulated at 1 Hz, MK-0448 (3 μM) shortened action potential duration at 90% of repolarization (APD(90)) and effective refractory period (ERP), but in permanent AF preparations, MK-0448 prolonged APD(90) and ERP. The effects of MK-0448 in intermittent AF resembled those in SR preparations. Block of I(Ks) is probably more prominent in AF because of reduced repolarization reserve due to AF-induced remodeling. Frontiers Media S.A. 2014-03-04 /pmc/articles/PMC3940943/ /pubmed/24624083 http://dx.doi.org/10.3389/fphar.2014.00026 Text en Copyright © 2014 Loose, Mueller, Wettwer, Knaut, Ford, Milnes and Ravens. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Loose, Simone
Mueller, Judith
Wettwer, Erich
Knaut, Michael
Ford, John
Milnes, James
Ravens, Ursula
Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation
title Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation
title_full Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation
title_fullStr Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation
title_full_unstemmed Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation
title_short Effects of I(Kur) blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation
title_sort effects of i(kur) blocker mk-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940943/
https://www.ncbi.nlm.nih.gov/pubmed/24624083
http://dx.doi.org/10.3389/fphar.2014.00026
work_keys_str_mv AT loosesimone effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation
AT muellerjudith effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation
AT wettwererich effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation
AT knautmichael effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation
AT fordjohn effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation
AT milnesjames effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation
AT ravensursula effectsofikurblockermk0448onhumanrightatrialactionpotentialsfrompatientsinsinusrhythmandinpermanentatrialfibrillation